DRTS

NASDAQ 已收盘

Alpha Tau Medical

11.31 USD
▼-0.70-5.83%
盘后 11.27 -0.35%
2026-11-19
市值
$1.09B
市盈率
—
EPS
-1.24
股息率
—
52 周区间
3.43 – 15.79
成交量
1.27M
Beta
1.29
目标价
21.00
52W 低 3.4352W 高 15.79
价格走势

公司简介

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the trea...